SecBot SecBot
8-K ·Filed Apr 24, 2026

NXGLW

NEXGEL, INC.
BEARISH
Impact 8/10
Horizonmonths Processed6mo ago SEC0001493152-26-018962
8-K context-dependent: Items 3.01
Actionable Insight ▼ Bearish

Monitor the stock price closely through October 19, 2026, to assess compliance progress. Watch for announcements regarding a reverse stock split or other corrective actions. Delisting would severely impact institutional ownership and liquidity, increasing volatility and reducing investor interest.

DirectionBearish
Confidencehigh
Horizonmonths
Final — all horizons settled through T+60d
NXGLW ▲ 0.00% at T+60d
SHORT call ✗ call lost 0.00% · α vs SPY +4.78% · entry $0.0550 → $0.0550
Entry = T+0 close
Apr 24, 2026
via day close
T+1d
0.00%
call 0.00% · α -0.49%
$0.0550
settled 6mo ago
T+5d
0.00%
call 0.00% · α +0.40%
$0.0550
settled 6mo ago
T+20d
-2.18%
call +2.18% · α +7.14%
$0.0538
settled 5mo ago
T+60d
0.00%
call 0.00% · α +4.78%
$0.0550
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

NexGel, Inc. received a Nasdaq deficiency notice because its common stock's closing bid price has been below $1.00 per share for 30 consecutive business days, violating the minimum bid price requirement. The company has until October 19, 2026, to regain compliance, potentially through a reverse stock split.

Key Facts

  • Nasdaq notified NexGel on April 22, 2026, that its common stock (NXGL) failed to maintain a minimum bid price of $1.00 for 30 consecutive business days.
  • The company has 180 calendar days, until October 19, 2026, to regain compliance by closing at or above $1.00 for 10 consecutive business days.
  • If compliance is not achieved by October 19, 2026, the company may qualify for an additional 180-day compliance period if it meets other listing standards and notifies Nasdaq of its intent to cure the deficiency, potentially via a reverse stock split.
  • Failure to regain compliance could result in delisting from Nasdaq, though the company has the right to appeal any delisting determination.

Financial Impact

Potential delisting risk and reduced liquidity; possible reverse stock split could lead to shareholder dilution or concentration.

stock priceliquiditymarket perceptionshareholder value

Risk Factors

  • Risk of delisting if the stock price does not recover to $1.00 or above for 10 consecutive days by October 19, 2026.
  • Potential negative market reaction to a reverse stock split, which may be perceived as a sign of financial distress.

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001493152-26-018962
Document: 0001493152-26-018962-index-headers.html0001493152-26-018962
Document: 0001493152-26-018962-index.html0001493152-26-018962
Document: 0001493152-26-018962.txt0001493152-26-018962
4 reports for NXGLW
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for NXGLW — sortable, filterable
TypeNow
May 15, 2026
23w ago
8-K
BEARISH ★ 7/10
$0.0550 $0.0387▲ +29.64%▲ +31.22%—
Apr 30, 2026
25w ago
8-K
NEUTRAL ★ 2/10
$0.0550 $0.0550· 0.00%▼ −5.27%—
Apr 24, 2026
26w ago
8-K
BEARISH ★ 8/10
$0.0550 $0.0538▲ +2.18%▲ +7.14%—
Apr 21, 2026
26w ago
8-K
BEARISH ★ 7/10
$0.0550 $0.0550· 0.00%▲ +3.17%—
Showing 4 of 4

US Market Status

Market Open — Closes in 1h 41m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 24, 2026